GH SecretagoguesResearch OnlyS

Hexarelin

Examorelin

Hexarelin (examorelin) is a synthetic hexapeptide GHRP with the highest GH-releasing potency among the GHRP class. Uniquely among GH secretagogues, hexarelin has demonstrated direct cardioprotective effects through CD36 receptor binding that are independent of GH release — making it of research interest for cardiac protection applications. Research use only; not FDA-approved.

XRedditFacebook
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
Studies cited
3
Research grade
S
Community score
84

Trend index

Trackers
1,296

Overview

About Hexarelin

Hexarelin (examorelin) is a synthetic hexapeptide GHRP with the highest GH-releasing potency among the GHRP class. Uniquely among GH secretagogues, hexarelin has demonstrated direct cardioprotective effects through CD36 receptor binding that are independent of GH release — making it of research interest for cardiac protection applications. Research use only; not FDA-approved.

Category
GH Secretagogues
Regulatory status
Research Only
Also known as
Examorelin
Self-reports
24

Community

What 24 users report

24 community reports

Positive 97% · Neutral 3% · Negative 0%

Most reported benefits

Recovery
143
Sleep
143
Energy
78

Most reported side effects

Water retention
5

Dose distribution

Median: 100–200 mcg · Most common: 100–200 mcg

0–25
0
25–50
0
50–100
0
100–200
84
200–400
59
400–600
0
600–1000
0
1000–2000
0
2000+
0

How repeat users are trending

Among repeat reporters, 87% said they felt similar to their last entry, 13% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 148 days · Based on 23 repeat reporters

Research

Cited research (2)

PubMed

Hexarelin, a synthetic growth hormone-releasing peptide, vs GHRH in GH-deficient adults

Ghigo et al., 1996

Source
Wiki study page →

Help

Frequently asked

What do PeptIQ users report about Hexarelin?

This page summarizes 24 anonymized self-reports from PeptIQ users who track Hexarelin, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.

What research is cited for Hexarelin?

2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.

Is Hexarelin safe to use?

This wiki does not assess safety or recommend use. Hexarelin is listed as Research Only. Consult a licensed clinician for personal medical decisions.

What are the purported benefits and uses of Hexarelin?

Research, primarily in animal models, suggests Hexarelin may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.

Source

What is the legal status of Hexarelin?

Hexarelin is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified Hexarelin as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.

Source

What are the known or theoretical side effects and risks of Hexarelin?

The safety and effectiveness of Hexarelin have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.

Source

What is the current state of research on Hexarelin?

While there are over 200 published studies on Hexarelin, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.

Source